Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics
Authors
Keywords
Breast cancer, SATB1, HER2, HR, Tumor histological grade, Prognosis
Journal
Diagnostic Pathology
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-08
DOI
10.1186/s13000-015-0282-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer
- (2015) Xiaohong Pu et al. PATHOLOGY RESEARCH AND PRACTICE
- Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays — preliminary study
- (2014) Christopher Kobierzycki et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Silencing SATB1 Inhibits the Malignant Phenotype and Increases Sensitivity of Human Osteosarcoma U2OS Cells to Arsenic Trioxide
- (2014) Haiying Zhang et al. International Journal of Medical Sciences
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
- (2012) Rocío García-Becerra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genome organizing function of SATB1 in tumor progression
- (2012) Terumi Kohwi-Shigematsu et al. SEMINARS IN CANCER BIOLOGY
- Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
- (2011) Todd W. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma
- (2011) Hongxiang Chen et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features
- (2010) CHAO CHENG et al. APMIS
- Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study
- (2010) C A Purdie et al. BRITISH JOURNAL OF CANCER
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- The mRNA expression of SATB1 and SATB2 in human breast cancer
- (2009) Neill Patani et al. Cancer Cell International
- Progression and treatment of HER2-positive breast cancer
- (2009) April Davoli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells
- (2009) Qing-Quan Li et al. CANCER SCIENCE
- SATB1 Defines the Developmental Context for Gene Silencing by Xist in Lymphoma and Embryonic Cells
- (2009) Ruben Agrelo et al. DEVELOPMENTAL CELL
- Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast
- (2008) M HUSSEIN et al. CELL BIOLOGY INTERNATIONAL
- Acetylation-Dependent Interaction of SATB1 and CtBP1 Mediates Transcriptional Repression by SATB1
- (2008) P. K. Purbey et al. MOLECULAR AND CELLULAR BIOLOGY
- SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis
- (2008) Hye-Jung Han et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started